Strategies for controlling glucose in the intensive care unit

Clinical Pulmonary Medicine

Volumn 13, Issue 6, 2006, Pages 332-347

  Hermayer, Kathie L ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Clinical Science Bldg ^*  (United States)

Author keywords

Diabetes; Glycemic control; Hypoglycemia; Insulin resistance; Intravenous insulin; Stress hyperglycemia

Indexed keywords

CORTICOSTEROID; GLUCOCORTICOID; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN GLULISINE; INSULIN LISPRO;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORTICOSTEROID THERAPY; CRITICAL ILLNESS; DIABETES MELLITUS; DIALYSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENTERIC FEEDING; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLYCEMIC CONTROL; HEART SURGERY; HEMOFILTRATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN TREATMENT; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; META ANALYSIS; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SAFETY; PRACTICE GUIDELINE; REVIEW; SYSTEMATIC REVIEW; TOTAL PARENTERAL NUTRITION; TREATMENT OUTCOME;

EID: 33750898271     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000250398.74075.96     Document Type: Review

References (61)

1. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992-1000.
2. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-2432.
3. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Bmj. 1997;314:1512-1515.
4. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
5. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-661.
6. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021.
7. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004;10(Suppl 2):21-33.
8. Furnary AP, Zerr KJ, Grunkemeier GL, et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67:352-360; discussion 360-352.
9. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma. 2003;55:33-38.
10. Langouche L, Van den Berghe G. Glucose metabolism and insulin therapy. Crit Care Clin. 2006;22:119-129.
11. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
12. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
13. Hirsch IB. Effect of insulin therapy on nonglycemic variables during acute illness. Endocr Pract. 2004;10(Suppl 2):63-70.
14. Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553-591.
15. Levetan CS, Magee MF. Hospital management of diabetes. Endocrinol Metab Clin North Am. 2000;29:745-770.
16. Magee MF. Insulin therapy for intensive glycemic control in hospital patients. Hospital Physician. 2006;38:17-27.
17. Le Roith D. Molecular mechanisms by which metabolic control may improve outcomes. Endocr Pract. 2004;10 Suppl 2:57-62.
18. Leahy JL, Bonner-Weir S, Weir GC. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care. 1992;15:442-455.
19. Steinberg HO, Brechtel G, Johnson A, et al. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94:1172-1179.
20. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest. 1996;98:894-898.
21. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.
22. Ridker PM, Rifai N, Pfeffer M, et al. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000;101:2149-2153.
23. Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767-1772.
24. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356-361.
25. Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;109:1497-1502.
26. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2004;164:2005-2011.
27. Mehta SR, Yusuf S, Diaz R, et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. Jama. 2005;293:437-446.
28. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
29. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-982.
30. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471-1478.
31. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998;22:77-81.
32. American Diabetes Association. Standards of Medical Care in Diabetes 2006. Diabetes Care. 2006;29(Suppl 1):S4-42.
33. Garber AJ, Moghissi ES, Bransome ED Jr, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10:77-82.
34. White NH, Skor D, Santiago JV. Practical closed-loop insulin delivery. A system for the maintenance of overnight euglycemia and the calculation of basal insulin requirements in insulin-dependent diabetics. Ann Intern Med. 1982;97:210-213.
35. Mao CS, Riegelhuth ME, Van Gundy D, et al. An overnight insulin infusion algorithm provides morning normoglycemia and can be used to predict insulin requirements in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1997;82:2466-2470.
36. Hawkins JB Jr, Morales CM, Shipp JC. Insulin requirements in 242 patients with type II diabetes mellitus. Endocr Pract. 1995;1:385-389.
37. Magee MF, Clement S. Subcutaneous insulin therapy in the hospital setting: issues, concerns, and implementation. Endocr Pract. 2004;10(Suppl 2):81-88.
38. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl 1):S5-20.
39. Ahmann A. Reduction of hospital costs and length of stay by good control of blood glucose levels. Endocr Pract. 2004;10(Suppl 2):53-56.
40. Estrada CA, Young JA, Nifong LW, et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003;75:1392-1399.
41. Van den Berghe G, Wouters PJ, Kesteloot K, et al. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006;34:612-616.
42. Hermayer K, Baliga P, Luttrell L. Outcomes of Tight Glycemic Control Utilizing a Diabetes Management Service Team in the Renal Transplant Patient (ABSTRACT). Diabetes. 2006;55:2661-PO.
43. Hirsch IB, Braithwaite SS, Verderese C. Practical Management of Inpatient Hyperglycemia. Hilliard Publishing; 2005.
44. Bode BW, Braithwaite SS, Steed RD, et al. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract. 2004;10(Suppl 2):71-80.
45. Dunnett JM, Steemson J, Sear JW, et al. Rapid restoration of normoglycaemia using intravenous insulin boluses. Diabetes Res. 1990;15:151-155.
46. Van den Berghe G. Insulin Therapy in Critical Illness. Int Diabetes Monitor. 2002;14:1-6.
47. Markovitz LJ, Wiechmann RJ, Harris N, et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract. 2002;8:10-18.
48. Trence DL, Kelly JL, Hirsch IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J Clin Endocrinol Metab. 2003;88:2430-2437.
49. Campbell K, Braithwaite S. Hospital Management of Hyperglycemia. Clinical Diabetes. 2004;22:81-88.
50. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27:461-467.
51. Bode B, Davidson P, Mather S. Evaluation of the glucose management system (GMS) for administering IV insulin therapy to hospitalized patients with diabetes (ABSTRACT). Diabetes. 1999;48.
52. Davidson PC, Steed RD, Bode BW. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 h of operation. Diabetes Care. 2005;28:2418-2423.
53. Hushion T, Kratz J, Arnold P. Outcomes of a cardiothoracic intensive care web-based online iv insulin infusion calculator study at a medial university hospital (abstract). ADA Late Breaking Abstracts. 2006;4-LB.
54. Richardson P, Steed R, Davidson P. Immediate correction of hypoglycemia without rebound using simple variable dosing of IV glucose (abstract). Diabetes. 1999;48:A363.
55. Hermayer K, Cawley P, Arnold P. Outcomes of a hypoglycemia treatment protocol in a medical university hospital (abstract). Diabetes. 2006;55:203-OR.
56. Shilo S, Berezovsky S, Friedlander Y, et al. Hypoglycemia in hospitalized nondiabetic older patients. J Am Geriatr Soc. 1998;46:978-982.
57. Hirsch IB, Paauw DS. Diabetes management in special situations. Endocrinol Metab Clin North Am. 1997;26:631-645.
58. Woolfson AM. An improved method for blood glucose control during nutritional support. JPEN J Parenter Enteral Nutr. 1981;5:436-440.
59. Coulston AM. Enteral nutrition in the patient with diabetes mellitus. Curr Opin Clin Nutr Metab Care. 2000;3:11-15.
60. Goldberg PA, Siegel MD, Russell RR, et al. Experience with the continuous glucose monitoring system in a medical intensive care unit. Diabetes Technol Ther. 2004;6:339-347.
61. Wilson DM, Block J. Real-time continuous glucose monitor use and patient selection: what have we learned and where are we going? Diabetes Technol Ther. 2005;7:788-791.